The antibody recognizes a functional epitope on human glucagon receptor and can be used to lower glucose levels in blood. It can be potentially used in the prevention and treatment of glucose-related disorders, including diabetes, hyperglycemia, hyperinsulinemia and so on.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-480 | Recombinant Human Anti-GCGR Antibody (mAb1) | WB, ELISA, FuncS | IgG |
HPAB-1620LY | Human Anti-GCGR Recombinant Antibody (clone CBL034) | ELISA, IHC | Human IgG |
HPAB-1621LY | Human Anti-GCGR Recombinant Antibody (clone CBL035) | ELISA, IHC | Human IgG |
HPAB-1622LY | Human Anti-GCGR Recombinant Antibody (clone CBL036) | ELISA, IHC | Human IgG |
ZG-0142U | Human Anti-GCGR Recombinant Antibody (clone 9G1) | ELISA | Humanized IgG1 |
There are currently no Customer reviews or questions for TAB-063CQ-F(E). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.